life scienc tool diagnost
price month
 close
guid light
ep top consensu abc ep beat
lower revenu off-set stronger profit factor
line ad rais ep guidanc
midpoint fulli reflect meaning beat lift
ep reflect out-performance partial off-set
temper profit balanc year
revenu miss plan profit prevail revenu improv
vs estimate distribut incl specialti acquisit rise
vs estimate rose well plan repres
profit albeit still compon posit thesi gross
margin bp bp plan oper expens bp
bp better plan ebit margin fell bp bp
plan focu area oper profit distribut climb nice
estimate gener billion cash fund
million share repurchas million dividend
reiter outperform expect admittedli low abc share
ytd vs broader regulatori pharmaci
drug price concern view abc latest result better fear
still manag re-affirmed oper guidanc year
impli temper profit experi crimp enthusiasm
latest beat await detail underli distribut profit
call area exceed expect well segment
dynam perform lacklust maintain posit
thesi view distributor better posit rel
peer predic driver larg pharmaci relationship
contribut non-cor unit risk demand opioid litig capit
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
global pharmaceut sourc
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
